New function for cell master regulator
Weill Institute researchers discover a new role for cells' master regulator
Proper turnover of proteins in the plasma membrane is critical for development and for day-to-day functions of every cell. The researchers sought to determine exactly how cells control the remodeling of these proteins at their surfaces. The study is published in Cell.
"The problem is you have hundreds of different proteins at the cell's surface, and all of them must be turned over in a certain, regulated way," said Jason MacGurn, a postdoctoral researcher in the Weill Institute for Cell and Molecular Biology, who co-led the study with graduate student, Pi-Chiang Hsu. MacGurn and Hsu work in the lab of Scott Emr, the paper's senior author and Weill Institute director.
"We've found a new role for TORC1 in coordinating protein turnover," added Emr.
In the paper, the researchers describe a cellular system that responds to changes in nutrient availability by degrading plasma membrane proteins. The study shows how TORC1 controls this process: When cells have access to nutrients, TORC1 is "on," and signals to inhibit an enzyme called Npr1. The inhibition of Npr1 activates a second protein called Art1, which facilitates the removal of specific proteins at the cell's surface. When cells are starving, TORC1 is "off," causing Npr1 to inhibit protein degradation by ejecting Art1 from the plasma membrane. This mechanism for regulating the degradation of plasma membrane proteins is a key feature of the cell's growth-control program.
Disruption of this process can lead to uncontrolled cell growth that contributes to the progression of many types of cancer. The type of control mechanism described by Emr and colleagues may also contribute to the control of obesity, since the proteins that correspond to Art1 in mice have also been shown to regulate body mass.
Organizations
Other news from the department science
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.